<DOC>
	<DOCNO>NCT02634697</DOCNO>
	<brief_summary>The purpose study determine eight week multimodal Relaxation Response Resiliency Program ( 3RP ) intervention effectively improve symptom severity , frequency quality life ( Q.O.L ) atrial fibrillation ( AF ) patient . This measured reduction AF symptom score , perceive stress , anxiety , hostility depression .</brief_summary>
	<brief_title>Impact Relaxation Response Resiliency Program Patients With Atrial Fibrillation</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) common cardiovascular disease . Symptoms include dizziness , palpitation , lightheadedness , shortness breath , fatigue exercise intolerance . AF also associate high risk complication like thrombo-embolism stroke , heart failure , dementia . The presence severity symptom complication adversely affect patient 's health relate quality life . Improvement quality life ( QOL ) important measure evaluate response treatment AF patient . Depression anxiety significant part psychosocial burden face approximately one-third AF patient , important component effect QOL patient . In study investigator apply 3RP ( Relaxation Response Resiliency Program - develop Benson Henry Institute Massachusetts General Hospital ) intervention among AF patient assess reduction stress , anxiety depression level reduction AF symptom burden severity .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Age : 1890 year 2 . Diagnosed documented recurrent symptomatic paroxysmal atrial fibrillation 3 . Currently stable medical therapy AF willing continue treatment regimen 8 week participate study . 4 . No current prior practice yoga , meditation , guide imagery technique elicit relaxation response ( RR ) . 5 . Able provide inform consent understand write spoken English . 1 . End Stage renal failure heart failure , severe unstable medical psychiatric disease 2 . Patients deem unable complete protocol due cognitive reason . 3 . Patients psychoactive medication eligibility determine PI MD coinvestigator casebycase basis , admit study medication deem stable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Relaxation Response Resiliency Program Intervention</keyword>
	<keyword>AF Symptom Severity Burden</keyword>
	<keyword>Stress , Anxiety , Depression Hostility</keyword>
	<keyword>Quality Life</keyword>
	<keyword>AF</keyword>
	<keyword>QOL</keyword>
	<keyword>3RP</keyword>
</DOC>